Select Soluble Mediators Inform a Refined Lupus Disease Activity Immune Index that Characterizes Clinical Disease Activity in Systemic Lupus Erythematosus

Source: https://ard.bmj.com/content/83/Suppl_1/19

Munroe M, Blankenship D, DeFreese D, Holloway A, Purushothaman M, DeJager W, Macwana S, Guthridge J, Kamp S, Redinger N, Aberle T, Chakravarty E, Arriens C, Li Y, Zeng H, Dezzutti S, Izmirly P, Thanarajasingam U, Kamen D, Buyon J, James JA, Jupe E. 2024. Select Soluble Mediators Inform a Refined Lupus Disease Activity Immune Index that Characterizes Clinical Disease Activity in Systemic Lupus Erythematosus [abstract]. Annals of the Rheumatic Diseases; 83 (Suppl 1) 403-404; DOI: 10.1136/annrheumdis-2024-eular.2153.